| Control (n = 30) | Severe asthma (n = 30) | P-value |
---|---|---|---|
Age | 39.23 ± 10.17 | 42.13 ± 9.41 | 0.26 |
Sex (M/F) | 13/17(43.3/56.7%) | 12/18 (40/60%) | – |
Age of asthma onset (Year) | – | 31.90 ± 10.55 |  |
FEV1 (% predicted) ± SD | 99.19 ± 10.99 | 51.37 ± 16.10 |  < 0.0001 |
FVC (% predicted) ± SD | 94.02 ± 8.39 | 63.50 ± 14.84 |  < 0.0001 |
FEV1/FVC | 0.85 ± 0.59 | 0.69 ± 0.11 |  < 0.0001 |
BMI (Mean ± SD) | 22.46 ± 2.28 | 23.30 ± 2.04 | 0.14 |
Blood eosinophil X 109 per L | 0.09 ± 0.04 | 0.52 ± 0.21 |  < 0.0001 |
Medication requirements (n) ICS(LABA and LAMA) / ICS + OCS | – | 10/20 | – |
Atopic (%) | Non | 80.0 (n = 24) | – |
Serum IgE IU/mL | 39.32 ± 5.33 | 232.8 ± 25.79 |  < 0.0001 |